US Stock MarketDetailed Quotes

CMND Clearmind Medicine

Watchlist

1.3400
-0.1300-8.84%

Close Nov 15 16:00 ET

1.3500
+0.0100+0.75%

Post 20:01 ET

5.46MMarket Cap-631P/E (TTM)

Clearmind Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Jul 31, 2024

(Q2)Apr 30, 2024

(Q1)Jan 31, 2024

(FY)Oct 31, 2023

(Q4)Oct 31, 2023

(Q3)Jul 31, 2023

(Q2)Apr 30, 2023

(Q1)Jan 31, 2023

(FY)Oct 31, 2022

(Q4)Oct 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

18.09%-1.13M

-11.55%-1.19M

52.89%-1.46M

-66.50%-4.56M

4,547.62%991.76K

-593.54%-1.38M

4.17%-1.07M

-121.63%-3.1M

-63.29%-2.74M

97.27%-22.3K

Net income from continuing operations

-264.04%-2.09M

56.26%-908.22K

27.99%-1.37M

-23.04%-6.23M

-76.23%-1.68M

49.12%-575.19K

-54.67%-2.08M

-15.93%-1.9M

-130.38%-5.07M

13.28%-954.8K

Operating gains losses

235.54%654.49K

-96.89%11.03K

-843.92%-41.67K

826.80%1.98M

--2.1M

---482.88K

--354.88K

--5.6K

--213.51K

----

Depreciation and amortization

-15.21%15.19K

15.87%15.74K

-60.76%8.63K

-31.87%41.59K

-169.15%-11.91K

-47.29%17.92K

4,243.09%13.58K

131.15%21.99K

3,914.99%61.04K

1,032.78%17.22K

Deferred tax

-374.71%-31.48K

-1,505.67%-130.26K

5,856.25%201.5K

-42.75%12.56K

-70.18%6.54K

---6.63K

--9.27K

--3.38K

--21.94K

Other non cash items

920.00%2.3K

461.38%1.63K

-99.96%1

-80.18%2.1K

-140.04%-804.9717

--225

--290

--2.39K

--10.61K

--2.01K

Change In working capital

88.51%-50.6K

-109.59%-57.51K

80.43%-296.11K

-177.11%-700.7K

18.10%653.15K

-201.33%-440.47K

2,230.28%599.6K

-2,875.35%-1.51M

5,814.15%908.72K

348.12%553.04K

-Change in receivables

67.65%-17.26K

-122.67%-21.49K

147.98%93.57K

-863.16%-111.81K

184.74%41.74K

-147.45%-53.35K

221.31%94.83K

-758.03%-195.03K

115.71%14.65K

-23.58%-49.26K

-Change in prepaid assets

-22.58%87.04K

-75.68%106.08K

59.65%-276.5K

-124.96%-18.9K

4,308.08%117.7K

923.59%112.43K

2,266.46%436.23K

-1,496.15%-685.26K

180.00%75.7K

97.04%-2.8K

-Change in payables and accrued expense

62.05%-127K

-8.51%-32.92K

58.35%-222.36K

-169.65%-570K

-45.66%328.8K

-207.51%-334.64K

-196.03%-30.34K

-311.99%-533.82K

302.65%818.37K

784.53%605.09K

-Change in other working capital

----

210.42%109.18K

----

---98.88K

----

Cash from discontinued investing activities

Operating cash flow

18.09%-1.13M

-11.55%-1.19M

52.89%-1.46M

-66.50%-4.56M

4,547.62%991.76K

-593.54%-1.38M

4.17%-1.07M

-121.63%-3.1M

-63.29%-2.74M

97.27%-22.3K

Investing cash flow

Cash flow from continuing investing activities

339.80%33.8K

-363.97%-18.97K

-552.00%-26.65K

7.69K

97.25%-4.09K

97.09%-4.09K

Net PPE purchase and sale

----

--0

----

79.14%-4.09K

----

Net intangibles purchase and sale

----

--0

----

--0

----

Net investment purchase and sale

--0

----

--0

----

Net other investing changes

----

---18.97K

---26.65K

----

Cash from discontinued investing activities

Investing cash flow

339.80%33.8K

----

-363.97%-18.97K

-552.00%-26.65K

--7.69K

----

97.25%-4.09K

97.09%-4.09K

Financing cash flow

Cash flow from continuing financing activities

1,581.84%469.54K

-95.07%145.13K

-16.25%5.32M

2,143.29%8.43M

-2,179.46%-824.7K

57.12%-31.69K

505.42%2.94M

6.35M

-91.35%375.98K

97.66%-36.18K

Net issuance payments of debt

-35.52%-13.47K

15.88%-12.79K

60.09%-6.3K

43.18%-29.59K

176.44%11.33K

73.32%-9.94K

---15.2K

---15.78K

---52.07K

---14.82K

Net common stock issuance

575.39%103.39K

--0

-71.33%1.82M

1,777.63%8.04M

-5,812.95%-1.26M

40.64%-21.75K

508.55%2.96M

--6.36M

-90.16%428.06K

98.62%-21.35K

Proceeds from stock option exercised by employees

--379.62K

--157.92K

--3.5M

--426.68K

--0

----

Cash from discontinued financing activities

Financing cash flow

1,581.84%469.54K

-95.07%145.13K

-16.25%5.32M

2,143.29%8.43M

-1,045.20%-824.7K

16.74%-31.69K

505.42%2.94M

--6.35M

-91.35%375.98K

95.34%-72.01K

Net cash flow

Beginning cash position

58.34%8.31M

175.60%9.29M

4,114.84%5.43M

-96.24%93.12K

1,192.59%3.85M

813.74%5.25M

52.89%3.37M

-96.43%128.78K

1,169.81%2.48M

-94.38%297.64K

Current changes in cash

55.46%-623.4K

-151.73%-969.15K

18.79%3.85M

263.18%3.86M

324.43%140.41K

-414.12%-1.4M

397.47%1.87M

331.73%3.24M

-193.69%-2.36M

97.50%-62.57K

Effect of exchange rate changes

-338.44%-2.88K

-464.36%-10.9K

188.14%3.72K

-63.93%-27.29K

-61.12%-27.26K

1,004.57%1.21K

521.60%2.99K

-1,234.23%-4.22K

---16.64K

---16.92K

End cash Position

99.61%7.68M

58.34%8.31M

175.60%9.29M

4,047.73%3.92M

1,192.59%3.85M

813.74%5.25M

52.89%3.37M

-96.52%94.62K

Free cash flow

18.09%-1.13M

-11.55%-1.19M

52.89%-1.46M

-66.25%-4.56M

3,858.62%991.76K

-593.54%-1.38M

4.17%-1.07M

-121.63%-3.1M

-51.20%-2.74M

97.21%-26.39K

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Jul 31, 2024	(Q2)Apr 30, 2024	(Q1)Jan 31, 2024	(FY)Oct 31, 2023	(Q4)Oct 31, 2023	(Q3)Jul 31, 2023	(Q2)Apr 30, 2023	(Q1)Jan 31, 2023	(FY)Oct 31, 2022	(Q4)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	18.09%-1.13M	-11.55%-1.19M	52.89%-1.46M	-66.50%-4.56M	4,547.62%991.76K	-593.54%-1.38M	4.17%-1.07M	-121.63%-3.1M	-63.29%-2.74M	97.27%-22.3K
Net income from continuing operations	-264.04%-2.09M	56.26%-908.22K	27.99%-1.37M	-23.04%-6.23M	-76.23%-1.68M	49.12%-575.19K	-54.67%-2.08M	-15.93%-1.9M	-130.38%-5.07M	13.28%-954.8K
Operating gains losses	235.54%654.49K	-96.89%11.03K	-843.92%-41.67K	826.80%1.98M	--2.1M	---482.88K	--354.88K	--5.6K	--213.51K	----
Depreciation and amortization	-15.21%15.19K	15.87%15.74K	-60.76%8.63K	-31.87%41.59K	-169.15%-11.91K	-47.29%17.92K	4,243.09%13.58K	131.15%21.99K	3,914.99%61.04K	1,032.78%17.22K
Deferred tax	-374.71%-31.48K	-1,505.67%-130.26K	5,856.25%201.5K	-42.75%12.56K	-70.18%6.54K	---6.63K	--9.27K	--3.38K	--21.94K	--21.94K
Other non cash items	920.00%2.3K	461.38%1.63K	-99.96%1	-80.18%2.1K	-140.04%-804.9717	--225	--290	--2.39K	--10.61K	--2.01K
Change In working capital	88.51%-50.6K	-109.59%-57.51K	80.43%-296.11K	-177.11%-700.7K	18.10%653.15K	-201.33%-440.47K	2,230.28%599.6K	-2,875.35%-1.51M	5,814.15%908.72K	348.12%553.04K
-Change in receivables	67.65%-17.26K	-122.67%-21.49K	147.98%93.57K	-863.16%-111.81K	184.74%41.74K	-147.45%-53.35K	221.31%94.83K	-758.03%-195.03K	115.71%14.65K	-23.58%-49.26K
-Change in prepaid assets	-22.58%87.04K	-75.68%106.08K	59.65%-276.5K	-124.96%-18.9K	4,308.08%117.7K	923.59%112.43K	2,266.46%436.23K	-1,496.15%-685.26K	180.00%75.7K	97.04%-2.8K
-Change in payables and accrued expense	62.05%-127K	-8.51%-32.92K	58.35%-222.36K	-169.65%-570K	-45.66%328.8K	-207.51%-334.64K	-196.03%-30.34K	-311.99%-533.82K	302.65%818.37K	784.53%605.09K
-Change in other working capital	----	----	210.42%109.18K	----	----	----	----	---98.88K	----	----
Cash from discontinued investing activities
Operating cash flow	18.09%-1.13M	-11.55%-1.19M	52.89%-1.46M	-66.50%-4.56M	4,547.62%991.76K	-593.54%-1.38M	4.17%-1.07M	-121.63%-3.1M	-63.29%-2.74M	97.27%-22.3K
Investing cash flow
Cash flow from continuing investing activities	339.80%33.8K			-363.97%-18.97K	-552.00%-26.65K	7.69K			97.25%-4.09K	97.09%-4.09K
Net PPE purchase and sale	----	----	----	--0	----	----	----	----	79.14%-4.09K	----
Net intangibles purchase and sale	----	----	----	--0	----	----	----	----	--0	----
Net investment purchase and sale	--0	----	----	----	----	--0	----	----	----	----
Net other investing changes	----	----	----	---18.97K	---26.65K	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	339.80%33.8K	----	----	-363.97%-18.97K	-552.00%-26.65K	--7.69K	----	----	97.25%-4.09K	97.09%-4.09K
Financing cash flow
Cash flow from continuing financing activities	1,581.84%469.54K	-95.07%145.13K	-16.25%5.32M	2,143.29%8.43M	-2,179.46%-824.7K	57.12%-31.69K	505.42%2.94M	6.35M	-91.35%375.98K	97.66%-36.18K
Net issuance payments of debt	-35.52%-13.47K	15.88%-12.79K	60.09%-6.3K	43.18%-29.59K	176.44%11.33K	73.32%-9.94K	---15.2K	---15.78K	---52.07K	---14.82K
Net common stock issuance	575.39%103.39K	--0	-71.33%1.82M	1,777.63%8.04M	-5,812.95%-1.26M	40.64%-21.75K	508.55%2.96M	--6.36M	-90.16%428.06K	98.62%-21.35K
Proceeds from stock option exercised by employees	--379.62K	--157.92K	--3.5M	--426.68K	--426.68K	--0	--0	--0	--0	----
Cash from discontinued financing activities
Financing cash flow	1,581.84%469.54K	-95.07%145.13K	-16.25%5.32M	2,143.29%8.43M	-1,045.20%-824.7K	16.74%-31.69K	505.42%2.94M	--6.35M	-91.35%375.98K	95.34%-72.01K
Net cash flow
Beginning cash position	58.34%8.31M	175.60%9.29M	4,114.84%5.43M	-96.24%93.12K	1,192.59%3.85M	813.74%5.25M	52.89%3.37M	-96.43%128.78K	1,169.81%2.48M	-94.38%297.64K
Current changes in cash	55.46%-623.4K	-151.73%-969.15K	18.79%3.85M	263.18%3.86M	324.43%140.41K	-414.12%-1.4M	397.47%1.87M	331.73%3.24M	-193.69%-2.36M	97.50%-62.57K
Effect of exchange rate changes	-338.44%-2.88K	-464.36%-10.9K	188.14%3.72K	-63.93%-27.29K	-61.12%-27.26K	1,004.57%1.21K	521.60%2.99K	-1,234.23%-4.22K	---16.64K	---16.92K
End cash Position	99.61%7.68M	58.34%8.31M	175.60%9.29M	4,047.73%3.92M	4,047.73%3.92M	1,192.59%3.85M	813.74%5.25M	52.89%3.37M	-96.52%94.62K	-96.52%94.62K
Free cash flow	18.09%-1.13M	-11.55%-1.19M	52.89%-1.46M	-66.25%-4.56M	3,858.62%991.76K	-593.54%-1.38M	4.17%-1.07M	-121.63%-3.1M	-51.20%-2.74M	97.21%-26.39K
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data